Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT01232374 · UNKNOWN
Trial details
- NCT number
- NCT01232374
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2015-10-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.